ATE505205T1 - Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1 - Google Patents

Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1

Info

Publication number
ATE505205T1
ATE505205T1 AT07818168T AT07818168T ATE505205T1 AT E505205 T1 ATE505205 T1 AT E505205T1 AT 07818168 T AT07818168 T AT 07818168T AT 07818168 T AT07818168 T AT 07818168T AT E505205 T1 ATE505205 T1 AT E505205T1
Authority
AT
Austria
Prior art keywords
hmgb1
box
polymer conjugates
variants
conjugates
Prior art date
Application number
AT07818168T
Other languages
English (en)
Inventor
Silvio Traversa
Chiara Lorenzetto
Valentina Mainero
Sebastiano Morena
Silvano Fumero
Luca Beccaria
Original Assignee
Creabilis Therapeutics Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creabilis Therapeutics Spa filed Critical Creabilis Therapeutics Spa
Priority claimed from PCT/EP2007/008029 external-priority patent/WO2008031612A1/en
Application granted granted Critical
Publication of ATE505205T1 publication Critical patent/ATE505205T1/de

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT07818168T 2006-09-15 2007-09-14 Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1 ATE505205T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06019362 2006-09-15
US90477607P 2007-03-05 2007-03-05
PCT/EP2007/008029 WO2008031612A1 (en) 2006-09-15 2007-09-14 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1

Publications (1)

Publication Number Publication Date
ATE505205T1 true ATE505205T1 (de) 2011-04-15

Family

ID=41095680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07818168T ATE505205T1 (de) 2006-09-15 2007-09-14 Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1

Country Status (8)

Country Link
CN (1) CN101528266B (de)
AT (1) ATE505205T1 (de)
BR (1) BRPI0718491A2 (de)
DE (1) DE602007013919D1 (de)
DK (1) DK2068935T3 (de)
PT (1) PT2068935E (de)
RU (1) RU2458070C2 (de)
SI (1) SI2068935T1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2834255C (en) * 2011-04-26 2021-11-02 Genomix Co., Ltd. Peptide for inducing regeneration of tissue and use thereof
CN102443064A (zh) * 2011-11-03 2012-05-09 刘誉 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
CN103893754A (zh) * 2012-12-26 2014-07-02 深圳先进技术研究院 Dna-壳聚糖复合纳米颗粒、其制备及应用
US9775885B2 (en) * 2016-01-29 2017-10-03 Kaohsiung Medical Univeristy TMD1 protein for treating bone loss diseases
CA3117107A1 (en) * 2018-10-25 2020-04-30 Osaka University Therapeutic agent for cartilage disorder
CN114957440A (zh) * 2022-05-26 2022-08-30 江苏大学 一种重组HMGB1 A Box蛋白及其获取方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK15422003A3 (sk) * 2001-05-15 2005-01-03 Research Institute North Shore-Long Island Jewish Použitie fragmentov HMG ako protizápalových činidiel
WO2006012373A2 (en) * 2004-07-20 2006-02-02 Critical Therapeutics, Inc. Combination therapies of hmgb and complement inhibitors against inflammation
BRPI0514835A (pt) * 2004-09-03 2008-06-24 Creabilis Therapeutics Spa variante de polipetìdeo de box de domìnio de ligação por alta afinidade de hmbg1 humano e/ou não humano ou de fragmento biologicamente ativo de box-a de hmgb1, molécula de ácido nucléico, uso, composição farmacêutica e dispositivo médico

Also Published As

Publication number Publication date
SI2068935T1 (sl) 2011-07-29
RU2458070C2 (ru) 2012-08-10
PT2068935E (pt) 2011-07-08
DK2068935T3 (da) 2011-08-01
CN101528266A (zh) 2009-09-09
DE602007013919D1 (de) 2011-05-26
CN101528266B (zh) 2012-11-07
BRPI0718491A2 (pt) 2013-12-03
RU2009114149A (ru) 2010-10-20

Similar Documents

Publication Publication Date Title
MX2009002820A (es) Conjugados polimericos de box-a de hmgb1 y variantes de box-a de hmgb1.
CY1121198T1 (el) Αντινοημaτικα μορια και μεθοδοι για την θεραπεια παθολογιων
ATE505205T1 (de) Polymerkonjugate von box-a von hmgb1 und box-a- varianten von hmgb1
FR21C1004I1 (de)
CY1116064T1 (el) Συστασεις αναστολεα ddp iv
EA201290964A1 (ru) Пептидные конъюгаты агонистов рецептора glp-1 и их применение
DE602005021072D1 (de) Adzyme und deren verwendungen
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
BRPI0820500A2 (pt) Variantes de alfa-amilase de bacillus sp. Ts-23 com propriedades alteradas
MX2007015935A (es) Agentes y metodos basados en el uso del dominio eda de la fibronectina.
DK1934353T3 (da) IL-15R alpha sushi domæner som en selektiv og effektiv forstærker af IL-15-virkningen gennem IL-15Rbeta/gamma, i hyperagonist IL-15 Ralpha sushi -IL 15 fusionsproteiner
BRPI0809583A2 (pt) polipeptídeos fgf-21 modificados e seus usos
EA201001883A1 (ru) Мутанты fgf21 и их применение
EA016245B9 (ru) Антитела против альфа2-интегрина и их применение
EA201990619A1 (ru) Fgf21 мутанты и их применение
ATE526361T1 (de) Antistatische und elektrisch leitfähige polyurethane
CR10852A (es) Compuestos biciclicos y su uso como anti-diabeticos
EA201401107A1 (ru) Специфические антагонисты рецептора fgf-r4
EA201101521A1 (ru) Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
CY1119800T1 (el) Συνδυασμοι υποδοχεα της 5-ητ4 και αναστολεων ακετυλοχολινεστερασης για τη θεραπεια γνωστικων διαταραχων
EA200800667A1 (ru) Аптамеры, связывающие тромбин с высокой аффинностью
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
NO20063856L (no) Behandling av psykoser med quetiapin-antipsykotiske midler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2068935

Country of ref document: EP